Beacon Financial Group Makes New Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Beacon Financial Group purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 5,879 shares of the company’s stock, valued at approximately $460,000.

A number of other institutional investors also recently modified their holdings of GEHC. CWM LLC grew its holdings in shares of GE HealthCare Technologies by 5.0% during the 3rd quarter. CWM LLC now owns 11,186 shares of the company’s stock valued at $1,050,000 after purchasing an additional 531 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in GE HealthCare Technologies by 1.7% in the third quarter. Exchange Traded Concepts LLC now owns 10,676 shares of the company’s stock valued at $1,002,000 after buying an additional 175 shares in the last quarter. Wesbanco Bank Inc. boosted its position in GE HealthCare Technologies by 14.6% in the third quarter. Wesbanco Bank Inc. now owns 17,027 shares of the company’s stock valued at $1,598,000 after buying an additional 2,175 shares in the last quarter. Swedbank AB grew its stake in shares of GE HealthCare Technologies by 6.6% during the third quarter. Swedbank AB now owns 72,013 shares of the company’s stock worth $6,758,000 after buying an additional 4,490 shares during the last quarter. Finally, Vontobel Holding Ltd. increased its holdings in shares of GE HealthCare Technologies by 71.0% during the third quarter. Vontobel Holding Ltd. now owns 41,294 shares of the company’s stock worth $3,875,000 after buying an additional 17,145 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $85.90 on Thursday. The stock’s 50 day moving average is $83.58 and its 200 day moving average is $85.39. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.55. The firm has a market cap of $39.25 billion, a P/E ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is 3.85%.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $96.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.